Evans John M.

CEO

Evans John M. has filed 5 SEC Form 4 filings (24 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Jul 1, 2026.

On the most recent filing, Evans John M. is listed as CEO at Beam Therapeutics Inc. Inside the rolling window, Evans John M. reported no open-market purchases and 9 open-market sales totaling $6.3M in BEAM. The largest disclosed transaction in the window is a sale of 25,000 BEAM shares on Jun 29, 2026, worth $887K.

Companies traded

Other insiders at BEAM

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$6.3M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
BEAMSale$887KJul 1SEC ↗
BEAMSale$858KJul 1SEC ↗
BEAMSale$739KApr 6SEC ↗
BEAMSale$559KApr 1SEC ↗
BEAMSale$569KApr 1SEC ↗
BEAMSale$735KFeb 2SEC ↗
BEAMSale$709KFeb 2SEC ↗
BEAMSale$613KOct 3SEC ↗
BEAMSale$616KOct 3SEC ↗
Showing 1–9 of 9
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Evans John M. made?

Evans John M. has filed 5 SEC Form 4 filings (24 transaction rows) across 1 company since 2025.

Which companies does Evans John M. trade?

Evans John M. has filed SEC Form 4 disclosures for 1 company, including BEAM.

When was Evans John M.'s most recent SEC Form 4 filing?

Evans John M.'s most recent SEC Form 4 filing on Tracefour is dated Jul 1, 2026.

What is Evans John M.'s job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Evans John M. is listed as CEO.

What is Evans John M.'s total buy and sell value in the current window?

Inside the rolling retention window, Evans John M. bought $0 and sold $6.3M based on SEC Form 4 filings.

What was Evans John M.'s largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 25,000 BEAM shares on 2026-06-29, worth $887K, per SEC Form 4 filings.